A YouGov survey in six European countries from late February to early March gathered data on the uptake of Corona vaccines from BioNTech/Pfizer, AstraZeneca and Moderna.
Corona vaccines have been a key issue in pandemic response since the end of 2020. More than 22 million Britons have already received the first vaccine dose, compared to only more than 5 million people in Germany. The British consider the vaccines from BioNTech/Pfizer (79%) and AstraZeneca (81%) to be almost equally safe. For the respondents in Germany, but also in other European countries such as France or Italy, this looks different: Two-thirds of Germans (66%) consider the Corona vaccine from BioNTech/Pfizer to be safe, while only 43% do so for the AstraZeneca vaccine. 54% speak positively about the vaccine from Moderna. More than a quarter of the German respondents (27%) would not want to be vaccinated with the AstraZeneca vaccine and would rather wait until they are offered another vaccine.
These are the results of a YouGov survey for which more than 8,000 people in Germany, France, Italy, Spain, the United Kingdom and the United States were interviewed using standardised online interviews from 23 February to 2 March 2021. The results are representative of the respective populations aged 18 and over.
Trust in AstraZeneca's Corona vaccine suffers greatly in the surveyed countries of mainland Europe, but also in the USA. The French are the most distrustful: only 33% of respondents in France say they feel the vaccine is safe. Among US-Americans, 42% say this, and among Italians it is slightly more than half (54%) who make this statement. Among Spaniards, 59% said this.
61% of the German respondents say that they would accept the vaccine of the manufacturer BioNTech/Pfizer, but only 35% say this about the vaccine of AstraZeneca. Half of the German respondents would accept the vaccine from Moderna (49%).